The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Lupin and its alliance partner Natco received clearance from the FDA for bosentan tablets for oral suspension, 32 mg, which ...

Previously only available at Walmart, the line is available at 1,400 CVS Pharmacy locations and on the retailer’s website ...

Tennessee Attorney General Jonathan Skrmetti is leading a bipartisan coalition urging the Food and Drug Administration to ...

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A lawsuit filed in the Singapore International Commercial Court is seeking $830 million in damages from KBP, with Novo ...

Potential serious side effects for Ozempic and Wegovy include possible thyroid tumors, including cancer; pancreatitis, vision changes, low blood sugar, kidney failure, gallbladder problems and ...